These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29581608)

  • 1. Physical Compatibility of Micafungin With Sodium Bicarbonate Hydration Fluids Commonly Used With High-Dose Methotrexate Chemotherapy.
    Joiner LC; Tynes C; Arnold J; Miller RR; Gorman G
    Hosp Pharm; 2018 Apr; 53(2):125-127. PubMed ID: 29581608
    [No Abstract]   [Full Text] [Related]  

  • 2. Compatibility of micafungin injection with other drugs during simulated y-site co-administration.
    Trusley C; Kupiec TC; Trissel LA
    Int J Pharm Compd; 2006; 10(3):230-3. PubMed ID: 23974236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
    Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL
    Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam.
    Wade J; Cooper M; Ragan R
    Hosp Pharm; 2015 May; 50(5):376-9. PubMed ID: 26405323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery.
    Teibel HM; Knoderer CA; Nichols KR
    Hosp Pharm; 2015 Sep; 50(8):710-3. PubMed ID: 26823620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.
    Housman ST; Tessier PR; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2011 Dec; 68(23):2265-70. PubMed ID: 22095816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium bicarbonate alters protein stability and blood coagulability in a simulated Impella purge gap model.
    Ammann KR; Ding J; Gilman V; Corbett S; Slepian MJ
    Artif Organs; 2023 Jun; 47(6):971-981. PubMed ID: 36633107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical compatibility of magnesium sulfate and sodium bicarbonate in a pharmacy-compounded hemofiltration solution.
    Moriyama B; Henning SA; Jin H; Kolf M; Rehak NN; Danner RL; Walsh TJ; Grimes GJ
    Am J Health Syst Pharm; 2010 Apr; 67(7):562-5. PubMed ID: 20237384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration.
    So W; Kim L; Thabit AK; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2017 Jan; 74(1):e55-e63. PubMed ID: 28007722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of sodium bicarbonate solutions in polyolefin bags.
    Wear J; McPherson TB; Kolling WM
    Am J Health Syst Pharm; 2010 Jun; 67(12):1026-9. PubMed ID: 20516474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
    Chan P; Bishop A; Kupiec TC; Trissel LA; Gole D; Jimidar IM; Vermeersch H
    Am J Health Syst Pharm; 2008 Aug; 65(16):1545-51. PubMed ID: 18693210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water.
    Meyer K; Santarossa M; Danziger LH; Wenzler E
    Hosp Pharm; 2017 Mar; 52(3):221-228. PubMed ID: 28439137
    [No Abstract]   [Full Text] [Related]  

  • 13. Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration.
    Patel K; Hursting MJ
    Am J Health Syst Pharm; 2005 Jul; 62(13):1381-4. PubMed ID: 15972381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Jul; 51(14):1792-9. PubMed ID: 7942908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physical compatibility of sodium bicarbonate with other drugs often administered in the intensive care unit].
    Ribas Nicolau B; Pérez Juan E; Amorós Cerdá SM; Arévalo Rubert MJ; Maqueda Palau M
    Enferm Intensiva; 2011; 22(2):78-82. PubMed ID: 21256788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administration.
    Thabit AK; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2017 Jan; 74(1):e47-e54. PubMed ID: 28007721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions.
    Marble DA; Bosso JA; Townsend RJ
    Am J Hosp Pharm; 1986 Jul; 43(7):1732-6. PubMed ID: 3529949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?
    Kufel WD; Miller CD; Johnson PR; Reid K; Zahra JJ; Seabury RW
    Hosp Pharm; 2017 Feb; 52(2):132-137. PubMed ID: 28321140
    [No Abstract]   [Full Text] [Related]  

  • 19. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
    Singh BN; Dedhiya MG; DiNunzio J; Chan P; Kupiec TC; Trissel LA; Laudano JB
    Am J Health Syst Pharm; 2011 Nov; 68(22):2163-9. PubMed ID: 22058102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of trimethoprim-sulfamethoxazole injection in two infusion fluids.
    Lesko LJ; Marion A; Ericson J; Siber GR
    Am J Hosp Pharm; 1981 Jul; 38(7):1004-6. PubMed ID: 7258196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.